Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-034927
Filing Date
2024-11-13
Accepted
2024-11-13 16:23:36
Documents
76
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vxrt20240930_10q.htm   iXBRL 10-Q 1844502
2 EXHIBIT 31.1 ex_716493.htm EX-31.1 16154
3 EXHIBIT 31.2 ex_716494.htm EX-31.2 16590
4 EXHIBIT 32.1 ex_716495.htm EX-32.1 12666
5 EXHIBIT 10.3 ex_743953.htm EX-10.3 326461
11 slide1.jpg GRAPHIC 47261
  Complete submission text file 0001437749-24-034927.txt   8330616

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20240930.xsd EX-101.SCH 62704
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vxrt-20240930_cal.xml EX-101.CAL 52177
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20240930_def.xml EX-101.DEF 440024
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20240930_lab.xml EX-101.LAB 385302
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20240930_pre.xml EX-101.PRE 473311
79 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20240930_10q_htm.xml XML 1285611
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 241454684
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)